Telangana recorded 33 fresh cases of COVID-19 on Sunday, taking the total number of those infected by the virus to 1,196 in the state, as the state-run Gandhi Hospital here is all set to carry out plasma therapy trials for coronavirus patients.
The plasma trials will be conducted from Monday as per the protocol of the Indian Council of Medical Research (ICMR), health officials said.
"This is a clinical trial. There is no proven researchon plasma therapy.
So, this is a research study under the guidance of ICMR and as part of it bloodis obtained from those recovered from COVID-19," a doctor at the hospital said.
"Depending on their (recovered patients) age group and hemoglobinper cent, and if they have any other complications, we will see all those andif they are fit then we will extract400 ml of blood from them," he said.
The therapy will be done for patients based on certain conditions such as lung capacity, he added.
The therapy aims at transfusing plasma (component of blood) containing antibodies donated by a recovered COVID-19 patient to the serious coronavirus patients harbouring an active infection.
According to a media bulletin on COVID-19, 33 new cases were confirmed, of which 26 were from Greater Hyderabad Municipal Corporation limits and another seven cases were migrants.
It said a total of 751 patients were discharged after treatment till date, however, no patient was discharged on Sunday.
No deaths were reported on Sunday and the figure remained at 30 in the state while the active cases stood at 415.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
